ArticleAnnals of clinical and translational neurology2025

Analysis of Soluble Interleukin-2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD.

Philipp Klyscz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.